Skip to search formSkip to main contentSkip to account menu

MTP-131

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Acute coronary syndromes: mechanisms, reperfusion injury, antithrombotic therapy, and current outcomes.
Download the Issue @ a Glance podcast Subscribe to the EHJ Podcast ![Graphic][1] The management and, as a consequence, the… 
2014
2014
Abstract 13960: Improved Mitochondrial Respiration in Left Ventricular Myocardium of Dogs with Heart Failure Following Long-term Therapy with Bendavia (MTP-131) is Associated with Suppression of the…
Introduction: An inflammatory state exists in heart failure (HF) evidenced by elevated cytokines including tumor necrosis factor… 
2014
2014
Abstract 85: Long-term Monotherapy with Bendavia (MTP-131), A Novel Mitochondria-Targeting Peptide, Restores H11 Kinase Protein Levels in Mitochondrial Fractions of Left Ventricular Myocardium of…
Background: The heat shock protein H11 kinase (H11K) is expressed in the heart of dogs, rodents and humans and rapidly increases… 
2014
2014
Abstract 12882: Monotherapy With Bendavia (MTP-131), a Novel Mitochondria-Targeting Peptide, Normalizes H11 Kinase Protein Levels in Nuclear and Mitochondrial Fractions of Left Ventricular Myocardium…
Introduction: The heat shock protein H11 kinase (H11K) is expressed in the heart and rapidly increases in response to increased… 
2013
2013
LONG-TERM THERAPY WITH BENDAVIA (MTP-131), A NOVEL MITOCHONDRIA-TARGETING PEPTIDE, INCREASES MYOCARDIAL ATP SYNTHESIS AND IMPROVES LEFT VENTRICULAR SYSTOLIC FUNCTION IN DOGS WITH CHRONIC HEART…
2013
2013
BENDAVIA (MTP-131), A NOVEL MITOCHONDRIA-TARGETING PEPTIDE, IMPROVES ACTIVITY AND EXPRESSION OF CYTOCHROME-C OXIDASE AND ATTENUATES MEDIATORS OF CARDIOMYOCYTE APOPTOSIS IN LEFT VENTRICULAR MYOCARDIUM…
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)